0001225208-12-011152.txt : 20120503
0001225208-12-011152.hdr.sgml : 20120503
20120503172208
ACCESSION NUMBER: 0001225208-12-011152
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120501
FILED AS OF DATE: 20120503
DATE AS OF CHANGE: 20120503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abate Thomas M
CENTRAL INDEX KEY: 0001346974
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 12810938
MAIL ADDRESS:
STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION
STREET 2: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4
1
doc4.xml
X0305
4
2012-05-01
0001099800
Edwards Lifesciences Corp
EW
0001346974
Abate Thomas M
ONE EDWARDS WAY
IRVINE
CA
92614
1
CVP, CFO
Common Stock
2012-05-01
4
M
0
10000.0000
22.9500
A
57902.0000
D
Common Stock
2012-05-01
4
S
0
1000.0000
82.7200
D
56902.0000
D
Common Stock
2012-05-01
4
S
0
1600.0000
83.9400
D
55302.0000
D
Common Stock
2012-05-01
4
S
0
7400.0000
84.4500
D
47902.0000
D
Employee Stock Option (Right to Acquire)
22.9500
2012-05-01
4
M
0
10000.0000
0.0000
D
2006-05-12
2012-05-11
Common Stock
10000.0000
16200.0000
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2011.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
This transaction was executed in multiple trades at prices ranging from $82.25 to $83.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $83.36 to $84.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $84.41 to $85.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Denise E. Botticelli, Attorney-in-Fact
2012-05-03